Articles - Articles
- Presidency conference ‘takes stock’ of personalised medicine
A landmark conference takes place in Luxembourg today (9 July) on personalised medicine, which is one of the thematic focuses of the new rotating presidency of the European Union.
The results of the high-level meeting, entitled ‘Making Access to Personalised Medicine a Reality for Patients’, will eventually feed in to Luxembourg’s Council Conclusions in December this year.
- Landmark personalised medicine conference under Luxembourg presidency
Last week, on the first of July, Luxembourg took over the rotating presidency of the European Union. On 8 July, a landmark high-level conference will take place on personalised medicine. This is one of the key elements of the presidency, which runs until 31 December.
Brussels-based EAPM (the European Alliance for Personalised Medicine) has been instrumental in putting personalised medicine on the political map and the results of the conference will eventually feed in to Luxembourg’s Council Conclusions in December this year.
- Luxembourg pushes personalised medicine agenda
Today, the first of July, Luxembourg takes over the rotating presidency of the European Union. The Duchy was one of the six founding member states of the organization that eventually became the 28-country EU that we know today.
As it turns out, current European Commission President, Jean-Claude Juncker, spent many years as Luxembourg’s prime minister and, thus, has been involved at European Council level for a great deal of time. One of the key elements – a thematic focus – of this presidency, which runs until 31 December, is the exciting new world of personalised medicine, and EAPM (the European Alliance for Personalised Medicine) has been instrumental in putting personalised medicine on the EU map and will be actively participating in the high-level conference taking place in the Duchy’s capital next week (8 July).
- Training vital for new era of patient-centric health care
“Health-care professionals cannot be expected to adapt to new ways of approaching patients and coping with new technology unless they are suitably trained”, a high-level conference on personalised medicine heard in Brussels this week.Delegates were told that it is vital to develop training for professionals whose disciplines are essential to the successful development of personalised medicine to promote the shared understanding and collaborative development of necessary tools. “To this end, employers, professional organizations, certification entities, regulatory agencies, and others will have to be involved in effecting the necessary changes,” the conference heard.
- Why personalised medicine needs incentives to match ‘value’
Personalised medicine is on the rise, there’s no doubt.
Mainly through the use of advancing developments in genetics, it has the ability to give the right treatment to the right patient at the right time, often work in a preventative way, improve quality of life for those already being treated, empower patients in decision-making processes and keep them out of expensive hospitals as much as possible, and even contribute to the amount of hours they spend in the workplace – mainly through a reduction in sick days.
- ‘Big Data’ should have patient welfare at its heart
‘Big Data’ is here and here to stay. We are sharing more and more information in more and more different ways and the trick, clearly, is how to use these data superhighways for the benefit of mankind.
One way to do that, in this era of fast-moving science and the advent of personalised medicine, is to put Europe’s 500 million potential patients across 28 EU member states at the heart of this incredible revolution.
- Timmermans’ ‘Better Regulation Plan’ is a step in right direction
This week saw the unveiling of the European Commission’s ‘Better Regulation Plan’, with its aim to streamline regulation, cut red tape and help the EU to be “big on big things, small on small things”.
Acting under the brief provided by Commission President Jean-Claude Juncker – who hailed the plan as one of his key policy goals – Commissioner Frans Timmermans said he and his colleagues are “determined to change both what the Union does and how it does it” and pointed out that citizens and businesses feel that: “Brussels and its institutions don’t always deliver rules they can understand or apply.”
- 100 million potential patients ‘not well-informed’ on cross-border health options
A major survey undertaken on behalf of the European Commission has shown that the experience of cross-border health care in the EU has changed little since 2007.
This is despite the implementation of a Directive on patients’ rights in cross-border health care more than a year prior to the poll.